EUVIMEDOpdag EUVIMED
Multizentrische StudieOpen access · CC BY-NC-ND 4.0

Addition of neoadjuvant chemotherapy to a ‘quadrifecta’ composite in radical cystectomy

David D'Andrea iD, Francesco Soria iD, Marco Moschini iD, Ekaterina Laukhtina iD, Rodolfo Hurle, Stefano Mancon, Alessandro Antonelli iD, Jeremy Yuen-Chun Teoh iD, Shahrokh F Shariat, Benjamin Pradere

BJU International · 2024

DOI: 10.1111/bju.16331 ↗

At a glance

Multizentrische Studie in BJU International, 2024. Written by David D'Andrea and 9 co-authors. Institution: Department of Urology, Medical University of Vienna, Vienna, Austria. Major MEDLINE topics: Cystectomy, Urinary Bladder Neoplasms, Neoadjuvant Therapy. Cited 1 times so far (Crossref); 21 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Objectives

To evaluate the impact of incorporating neoadjuvant chemotherapy (NAC) into the ‘quadrifecta’ outcomes composite for reporting outcomes of radical cystectomy (RC) creating a pentafecta score. Patients and Methods This is a retrospective multicentre analysis of patients treated with RC, with or without NAC, for bladder cancer between 2002 and 2023. The primary outcome was the effect of adding NAC to a quadrifecta outcomes composite on cancer‐specific (CSS) and overall survival (OS). The quadrifecta outcomes composite included a yield of ≥16 lymph nodes, negative soft tissue surgical margin, absence of major complication within 30 days from surgery, and no delay in RC.

Results

A total of 590 patients were included in the analyses. A total of 233 (39.5%) patients achieved all quadrifecta outcomes and 82 (13.9%) patients were additionally treated with NAC, achieving the pentafecta. Achieving the quadrifecta outcomes composite was significantly associated with better CSS (hazard ratio [HR] 0.49, 95% confidence interval [CI] 0.32–0.75; P = 0.001) and OS (HR 0.48, 95% CI 0.34–0.69; P < 0.01). The addition of NAC to the quadrifecta composite outcomes significantly improved the discrimination of patients more likely to have better CSS (HR 0.21, 95% CI 0.08–0.57; P = 0.002) and OS (HR 0.26, 95% CI 0.12–0.55; P < 0.01).

Conclusion

We propose a new pentafecta that may serve as a tool for standardising outcomes reporting and measuring the quality of RC.

Subjects

MeSH terms (MEDLINE)

CystectomyUrinary Bladder NeoplasmsNeoadjuvant TherapyHumansMaleRetrospective StudiesFemaleAgedMiddle AgedChemotherapy, AdjuvantTreatment Outcome

Author keywords

bladder cancercomposite outcomesneoadjuvant chemotherapyradical cystectomysurvival

Authors and institutions

  • Department of Urology, Medical University of Vienna, Vienna, Austria.
  • Department of Urology, AOU Città della Salute e della Scienza, Torino School of Medicine, Turin, Italy.
  • Department of Urology, IRCCS Ospedale San Raffaele and Vita-Salute San Raffaele University, Milan, Italy.
  • Department of Urology, IRCCS Humanitas Clinical and Research Hospital, Rozzano, Italy.
  • Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
  • UOC Urologia, Azienda Ospedaliera Universitaria Integrata Di Verona, Verona, Italy.

ORCID profiles: David D'Andrea, Francesco Soria, Marco Moschini, Ekaterina Laukhtina, Alessandro Antonelli, Jeremy Yuen-Chun Teoh

Cite

APA

D'Andrea, D., Soria, F., Moschini, M., Laukhtina, E., Hurle, R., Mancon, S., Antonelli, A., Teoh, J. Y., Shariat, S. F., & Pradere, B. (2024). Addition of neoadjuvant chemotherapy to a ‘quadrifecta’ composite in radical cystectomy. BJU International. https://doi.org/10.1111/bju.16331

Vancouver

D'Andrea D, Soria F, Moschini M, Laukhtina E, Hurle R, Mancon S, et al. Addition of neoadjuvant chemotherapy to a ‘quadrifecta’ composite in radical cystectomy. BJU International. 2024. doi:10.1111/bju.16331

BibTeX
@article{DAndrea2024,
  author = {D'Andrea, David and Soria, Francesco and Moschini, Marco and Laukhtina, Ekaterina and Hurle, Rodolfo and Mancon, Stefano and Antonelli, Alessandro and Teoh, Jeremy Yuen-Chun and Shariat, Shahrokh F and Pradere, Benjamin},
  title = {Addition of neoadjuvant chemotherapy to a ‘quadrifecta’ composite in radical cystectomy},
  journal = {BJU International},
  year = {2024},
  doi = {10.1111/bju.16331}
}
Start for free →